Article 1
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2024/324 of 19 January 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, bromuconazole, buprofezin, cyflufenamid, fluazinam, fluopyram, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metsulfuron-methyl, phosphane and pyraclostrobin
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .
ANNEX The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: 1. Part A is amended as follows: (1) in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘15 May 2025’; (2) in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘15 September 2025’; (3) in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘15 June 2025’; (4) in the sixth column, expiration of approval, of row 189, Fluazinam, the date is replaced by ‘15 April 2026’; (5) in the sixth column, expiration of approval, of row 191, Mepiquat, the date is replaced by ‘15 October 2025’; (6) in the sixth column, expiration of approval, of row 296, Cyflufenamid, the date is replaced by ‘30 June 2027’; (7) in the sixth column, expiration of approval, of row 318, Bromuconazole, the date is replaced by ‘30 April 2027’; (8) in the sixth column, expiration of approval, of row 320, Buprofezin, the date is replaced by ‘15 December 2025’. 2. Part B is amended as follows: (1) in the sixth column, expiration of approval, of row 28, Phosphane, the date is replaced by ‘15 March 2026’; (2) in the sixth column, expiration of approval, of row 51, Fluopyram, the date is replaced by ‘30 June 2026’. 3. Part E is amended as follows: (1) in the sixth column, expiration of approval, of row 3, Metsulfuron-methyl, the date is replaced by ‘31 August 2026’; (2) in the sixth column, expiration of approval, of row 4, Benzovindiflupyr, the date is replaced by ‘2 August 2026’; (3) in the sixth column, expiration of approval, of row 5, Lambda-cyhalothrin, the date is replaced by ‘31 August 2026’.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.